Cargando...
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
BACKGROUND: Stroke is a leading cause of death and disability world wide. Thrombolysis with recombinant tissue plasminogen activator (rt‐PA) is licensed for treatment of acute ischaemic stroke in the early hours after symptom onset. It has been shown in randomised controlled trials (RCTs) and the 20...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2013
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045424/ https://ncbi.nlm.nih.gov/pubmed/23728633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000514.pub3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|